The global crisaborole market size was valued at approximately USD 1.5 billion in 2023 and is expected to grow significantly to reach around USD 3.8 billion by 2032, exhibiting a CAGR of 10.5% during the forecast period. This substantial growth is primarily attributed to the increasing prevalence of dermatological conditions such as atopic dermatitis, psoriasis, and eczema worldwide.